Literature DB >> 28056534

Episodic status migrainosus: A novel migraine subtype.

Tarun D Singh1,2, F Michael Cutrer1, Jonathan H Smith2.   

Abstract

Objective To report a case series of a novel migraine subtype, which we term as episodic status migrainosus (ESM), characterized by attacks of migraine exclusively lasting more than 72 hours. We hypothesized that this would represent a novel nosologic entity, possibly an unstable migraine phenotype with a high conversion rate to chronic migraine (CM). Methods We conducted a retrospective review of patients diagnosed with status migrainosus at the Mayo Clinic, Rochester, between January 2005 and December 2015. All the records were then manually reviewed for patients with migraine headaches exclusively lasting more than 72 hours. Results We identified 18 patients with ESM, with a female predominance (15(83.3%)) and a median age of onset of 16.5 (IQR 13-19) years. The median monthly attack frequency was two (IQR 1-3), with each attack lasting a median duration of seven (IQR 4-12.5) days. Stress was the most commonly reported precipitant (11 (61.1%)). Migraine with aura was common (10 (55.6%)), as was comorbid depression (10 (55.6%)). Fifteen (83.3%) patients developed CM at a median of 7.8 (IQR 2.6-21.9) years from their first attack. There was no significant association between the time to the development of chronic migraine with either attack frequency or duration. Conclusions and relevance We report the existence of a novel migraine subtype, episodic status migrainosus. This migraine subtype appears to have similar clinical characteristics to episodic migraine with or without aura, except for a notably high tendency to progress to chronic migraine.

Entities:  

Keywords:  Migraine; chronic migraine; depression; episodic status migrainosus; headache; status migrainosus

Mesh:

Year:  2017        PMID: 28056534     DOI: 10.1177/0333102416686341

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  4 in total

1.  Predictors of Short-Term Prognosis While in Pediatric Headache Care: An Observational Study.

Authors:  Serena L Orr; Abigail Turner; Marielle A Kabbouche; Paul S Horn; Hope L O'Brien; Joanne Kacperski; Susan LeCates; Shannon White; Jessica Weberding; Mimi N Miller; Scott W Powers; Andrew D Hershey
Journal:  Headache       Date:  2019-01-23       Impact factor: 5.887

2.  Intravenous mannitol in status migrainosus treatment: a clinical case series.

Authors:  Roberto De Simone; Angelo Ranieri; Guido Ferra; Federico Cautiero
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

Review 3.  Emergency Department and Inpatient Management of Headache in Adults.

Authors:  Jennifer Robblee; Kate W Grimsrud
Journal:  Curr Neurol Neurosci Rep       Date:  2020-03-18       Impact factor: 5.081

4.  The Association Between Hospital Length of Stay and Treatment With IV Magnesium in Patients With Status Migrainosus.

Authors:  William Hoffman; James Aden; Randall Bossler; Joshua Luster; Morgan Jordan
Journal:  Neurohospitalist       Date:  2020-11-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.